CacheBy
Thermo Fisher Scientific ErbB2 (HER-2) Monoclonal Antibody (2G11), Biotin, eBioscience
원본

Thermo Fisher Scientific ErbB2 (HER-2) Monoclonal Antibody (2G11), Biotin, eBioscience

상품 한눈에 보기

HER-2 단백질을 표적하는 Biotin 결합 단클론 항체로, 인간 시료에 반응하며 Flow Cytometry, WB, ICC/IF, IP에 활용 가능. HER-2 과발현 암 연구에 적합하며, 고순도(>95%)로 제조됨. 2-8°C 보관, 연구용 전용.

카탈로그번호
BMS120BT
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 04. 오전 11:19
Thermo Fisher Scientific BMS120BT ErbB2 (HER-2) Monoclonal Antibody (2G11), Biotin, eBioscience 100 tests pk판매 단위 pk ·
재고 확인 필요
409,600원VAT 포함 450,560원

Thermo Fisher Scientific · Thermo Fisher Scientific ErbB2 (HER-2) Monoclonal Antibody (2G11), Biotin, eBioscience

Applications and Tested Dilutions

Application Tested Dilution Publications
Western Blot (WB) View 1 publication
Immunocytochemistry (ICC/IF) View 1 publication
Flow Cytometry (Flow) Assay-Dependent
Immunoprecipitation (IP) View 1 publication

Product Specifications

항목 내용
Species Reactivity Human
Published Species Human
Host / Isotype Mouse / IgG1
Recommended Isotype Control Mouse IgG1 kappa Isotype Control (P3.6.2.8.1), Biotin, eBioscience™
Class Monoclonal
Type Antibody
Clone 2G11
Conjugate Biotin
Form Liquid
Concentration 10 µL/Test
Purification Affinity chromatography
Storage Buffer TBS, pH 7.2–7.4, with 1% BSA
Contains 0.02% sodium azide
Storage Conditions 2–8°C
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_10598667
Purity >95%

Available Formats


Product Specific Information

The antibody (clone 2G11) can be used to stain cryostat sections or cell smears.
BMS120 is suitable as a primary antibody for FACS analysis.
BMS120FI can be used for direct staining of cells, while BMS120BT can be applied in a two-step procedure using the biotin-(strept)avidin system.

The epitope is located in the extracellular domain, and no cross-reactivity with EGF-R has been detected by immunoprecipitation.

HER-2 oncogene amplification and oncoprotein overexpression have been correlated with breast, ovarian, gastric, lung, and other cancers.
In 15–40% of primary breast cancers, HER-2 amplification is found and is highly correlated with overexpression of the encoded protein, playing a major role in the initiation of ductal carcinomas. HER-2 overexpression serves as an independent prognostic factor with greater predictive power than most current prognostic tools, especially in axillary lymph-node-positive breast cancer patients.

Approximately 32% of ovarian carcinomas overexpress the HER-2 oncoprotein, and survival of these patients is significantly worse compared with cases of normal HER-2 expression. Patients with high HER-2 expression also show lower complete response rates to primary therapy.
A correlation between HER-2 expression and clinical outcome has been demonstrated for head and neck, salivary gland, and placental carcinomas.

HER-2 is useful in identifying cancer cells with increased aggressiveness.
Soluble p97-115 HER-2 (the circulating fragment of p185 HER-2) levels in serum can be used as a diagnostic tool for monitoring tumor spread, postoperative relapse, and metastatic risk in various cancers.

Applications Tested: Flow Cytometry.


Target Information

ErbB2 (HER2) is a receptor tyrosine kinase overexpressed in certain breast tumors.
Herceptin, a monoclonal antibody targeting this kinase, is used in the treatment of metastatic HER2-positive cancers.


For Research Use Only. Not for use in diagnostic procedures.
Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.